PMCB
PharmaCyte Biotech, Inc.
+0.01 (+1.61%)0.42USD324K成交股數4.5M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 4 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 60K | 62K | 93K | 141K | 95K | 118K | 97K | 96K | 94K | 127K | 82K | 104K |
| 銷售管理費用 | 947K | 900K | 2.0M | 1.2M | 753K | 842K | 1.0M | 1.2M | 4.2M | 252K | 273K | 1.4M |
| 營業利益 | −1.0M+19% | −2.5M+162% | −2.1M+91% | −1.4M+8% | −848K-73% | −960K-49% | −1.1M-22% | −1.3M-39% | −3.2M | −1.9M | −1.4M | −2.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.1M-39% | −4.4M+44% | 747K-151% | −7.4M-132% | −8.4M-721% | −3.0M+392% | −1.5M-153% | 23.4M-836% | 1.3M | −620K | 2.8M | −3.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.54-56% | -0.13-70% | -0.17-56% | -1.24-165% | -1.23+251% | -0.44-32% | -0.39+50% | 1.90-452% | -0.35 | -0.65 | -0.26 | -0.54 |
| 稀釋股數 | 10.7M | 8.4M | 9.3M | 6.8M | 6.8M | 7.0M | 7.6M | 7.9M | 9.6M | 8.6M | 8.8M | 12.6M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 17.7M | 18.6M | 20.2M | 15.4M | 13.2M | 16.4M | 20.8M | 32.6M | 50.2M | 61.2M | 73.4M | 74.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 36.7M | 46.8M | 55.9M | 56.0M | 45.1M | 43.8M | 55.1M | 70.2M | 59.9M | 71.4M | 78.9M | 79.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 6.9M | 11.8M | 16.5M | 19.4M | 1.5M | 3.6M | 11.6M | 17.2M | 20.4M | 22.5M | 20.8M | 20.4M |
| 股東權益 | 27.5M | 33.3M | 38.1M | 35.2M | 43.6M | 40.3M | 43.5M | 47.7M | 27.6M | 31.4M | 36.8M | 39.2M |
| 負債比 | 18.8% | 25.2% | 29.5% | 34.7% | 3.4% | 8.2% | 21.1% | 24.4% | 34.0% | 31.5% | 26.4% | 25.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −781K-61% | – | – | – | −2.0M | – | – | −373K-209% | – | – | – | 343K |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | 0 | – | – | 742K | 1.2M | 405K | 165K | 26.5M |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 0 | – | −19.4M | –% | -2.77 | – |
| FY2025 | 0 | – | 30.7M | –% | 3.19 | – |
| FY2024 | 0 | – | 334K | –% | -1.80 | – |
| FY2023 | 0 | – | −4.3M | –% | -0.22 | – |
| FY2022 | 0 | – | −4.2M | –% | -0.27 | – |
| FY2021 | 0 | – | −3.6M | –% | -2.45 | – |
| FY2020 | 0 | – | −3.8M | –% | -4.23 | – |
| FY2019 | 0 | – | −4.1M | –% | 0.00 | – |